Uniplan Investment Counsel, Inc. Cerus Corp Transaction History

Uniplan Investment Counsel, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.79 - $2.9 $8,907 - $14,430	-4,976 Reduced 0.5%	986,723 $2.43 Million
Q1 2023 May 15, 2023	SELL	$2.65 - $3.81 $126,405 - $181,737	-47,700 Reduced 4.59%	991,699 $2.95 Million
Q4 2022 Feb 14, 2023	BUY	$3.38 - $4.22 $863,032 - $1.08 Million	255,335 Added 32.57%	1,039,399 $3.79 Million
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.83 $1.38 Million - $2.34 Million	402,071 Added 105.26%	784,064 $2.82 Million
Q2 2022 Aug 15, 2022	BUY	$4.41 - $5.69 $1.68 Million - $2.17 Million	381,993 New	381,993 $2.02 Million

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $294M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Uniplan Investment Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on Uniplan Investment Counsel, Inc. with notifications on news.